Atropine Sulfate Injection · #1 of 35 active shortages by FDA posting duration
Brand: ATROPINE SULFATE
FDA lists Atropine Sulfate Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Atropine Sulfate Injection: Active Shortage
Available 18 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Atropine Sulfate Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)
- Package NDC
- 63323-580-20
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Jan 1, 2012
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Anesthesia, Neurology, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory
Full Drug Profile
atropine
Side effects, interactions, warnings & more
Nearby, Other Atropine Shortage Records
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
American Regent, Inc.
Injection
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
American Regent, Inc.
Injection
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.